CanSino Biologics Inc. (6185.HK)
HKD 30.45
(-1.77%)
HKD 30.45
(-1.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 345.18 Million | 1.03 Billion | 4.29 Billion | 18.54 Million | 2.28 Million | 1.13 Million |
| Cost of Revenue | 1.22 Billion | 1.21 Billion | 1.29 Billion | 13.8 Million | 147.46 Thousand | 113.64 Million |
| Gross Profit | -876.01 Million | -186.6 Million | 3 Billion | 4.74 Million | 2.13 Million | -112.51 Million |
| Operating Expenses | 1.2 Billion | 1.26 Billion | 1.2 Billion | 445.06 Million | 204.2 Million | 152.35 Million |
| Selling, General and Administrative Expenses | 647.84 Million | 544.68 Million | 337.63 Million | 99.43 Million | 68.07 Million | 20.6 Million |
| Research and Development Expenses | 637.98 Million | 778.25 Million | 878.71 Million | 428.48 Million | 151.74 Million | 113.64 Million |
| Other Expenses | -335 Thousand | -60.97 Million | -14.99 Million | -82.85 Million | -15.61 Million | 100 Thousand |
| Cost and Expenses | 2.38 Billion | 2.47 Billion | 2.49 Billion | 458.86 Million | 204.2 Million | 152.35 Million |
| Operating Income | -2.03 Billion | -1.36 Billion | 1.91 Billion | -440.32 Million | -202.07 Million | -138.57 Million |
| Interest Expense | 64.34 Million | 41.34 Million | 20.41 Million | 140 Thousand | - | - |
| Income Tax Expense | -11.45 Million | -219.24 Million | 29.7 Million | -38.14 Million | -3.65 Million | -12.54 Million |
| Earnings before Tax | -1.97 Billion | -1.18 Billion | 1.93 Billion | -396.63 Million | -156.76 Million | -138.28 Million |
| Net Income | -1.48 Billion | -964.75 Million | 1.91 Billion | -358.49 Million | -153.1 Million | -138.28 Million |
| Earnings Per Share Basic | -6.01 | -3.91 | 7.74 | -1.55 | -0.75 | -0.63 |
| Earnings Per Share Diluted | -6.01 | -3.91 | 7.74 | -1.55 | -0.75 | -0.63 |
| Weighted Average Shares Outstanding | 246.76 Million | 247.02 Million | 247.44 Million | 230.6 Million | 203.25 Million | 218.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 246.76 Million | 247.02 Million | 247.45 Million | 230.91 Million | 203.45 Million | 218.19 Million |
| Gross Margin | -2.54 | -0.18 | 0.70 | 0.26 | 0.94 | -99.39 |
| EBIT Margin | -4.77 | -1.00 | 0.46 | -21.73 | -60.41 | -122.62 |
| Profit Margin | -4.30 | -0.94 | 0.45 | -19.33 | -67.05 | -122.16 |
| EBITDA | -1.64 Billion | -1.02 Billion | 1.97 Billion | -402.96 Million | -204.89 Million | -126.26 Million |
| Earnings Before Tax Margin | -5.90 | -1.33 | 0.44 | -23.74 | -88.50 | -122.42 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 171.13 Million | 114.28 Million | 345.18 Million | 169.55 Million | 154.54 Million | -79.46 Million |
| Cost of Revenue | 52.03 Million | 46.23 Million | 1.22 Billion | 1.04 Billion | -624.85 Million | 732.38 Million |
| Gross Profit | 119.1 Million | 68.04 Million | -876.01 Million | -878.93 Million | 779.4 Million | -811.85 Million |
| Operating Expenses | 180.57 Million | 173.77 Million | 1.2 Billion | 353.47 Million | 291.5 Million | 324.05 Million |
| Selling, General and Administrative Expenses | 153.66 Million | 46.58 Million | - | 266.12 Million | 112.82 Million | 213.91 Million |
| Research and Development Expenses | 89.15 Million | 96.74 Million | - | 176.31 Million | 123.3 Million | 188.6 Million |
| Other Expenses | 525.71 Thousand | -1719.70 | -335 Thousand | 40.36 Million | -8.33 Million | -24.24 Million |
| Cost and Expenses | 232.6 Million | 220.01 Million | 2.42 Billion | 1.4 Billion | -333.35 Million | 1.05 Billion |
| Operating Income | -75.58 Million | -174.88 Million | -2.03 Billion | -957.15 Million | 684.71 Million | -1.15 Billion |
| Interest Expense | 18.04 Million | 14.67 Million | 64.14 Million | 18.18 Million | 16.68 Million | 20.5 Million |
| Income Tax Expense | 964 Thousand | -4.78 Million | -11.45 Million | -10.28 Million | 179.17 | 29.1 Million |
| Earnings before Tax | -54.31 Million | -174.88 Million | -1.97 Billion | -522.8 Million | -172.74 Million | -1.08 Billion |
| Net Income | -55.27 Million | -170.09 Million | -1.48 Billion | -497.7 Million | -143.6 Million | -701.88 Million |
| Earnings Per Share Basic | -0.22 | -0.69 | - | -2.02 | -0.58 | -2.82 |
| Earnings Per Share Diluted | -0.22 | -0.69 | - | -2.02 | -0.58 | -2.82 |
| Weighted Average Shares Outstanding | 247.16 Million | 246.51 Million | 246.76 Million | 246.21 Million | 247.04 Million | 248.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 247.16 Million | 246.51 Million | 246.76 Million | 246.21 Million | 247.11 Million | 248.68 Million |
| Gross Margin | 0.70 | 0.60 | -2.54 | -5.18 | 5.04 | 10.22 |
| EBIT Margin | 0.08 | -1.25 | - | -8.04 | 4.43 | 13.75 |
| Profit Margin | -0.32 | -1.49 | -4.30 | -2.94 | -0.93 | 8.83 |
| EBITDA | 14.18 Million | -143.06 Million | - | -1.36 Billion | 684.71 Million | -1.09 Billion |
| Earnings Before Tax Margin | -0.44 | -1.53 | -5.90 | -5.65 | 4.43 | 14.47 |
SRU-UN
PYRAMID
UTHR
NOU
KETL
KIN2